TY  - GEN
AU  - Vignetti,Marco
AU  - Fazi,Paola
AU  - Cimino,Giuseppe
AU  - Martinelli,Giovanni
AU  - Di Raimondo,Francesco
AU  - Ferrara,Felicetto
AU  - Meloni,Giovanna
AU  - Ambrosetti,Achille
AU  - Quarta,Giovanni
AU  - Pagano,Livio
AU  - Rege-Cambrin,Giovanna
AU  - Elia,Loredana
AU  - Bertieri,Raffaello
AU  - Annino,Luciana
AU  - Foà,Robin
AU  - Baccarani,Michele
AU  - Mandelli,Franco
TI  - Imatinib plus steroids induces complete remissions and prolonged survival in elderly Philadelphia chromosome-positive patients with acute lymphoblastic leukemia without additional chemotherapy: results of the Gruppo Italiano Malattie Ematologiche dell'Adulto (GIMEMA) LAL0201-B protocol
SN  - 0006-4971
PY  - 2007///0605
KW  - Aged
KW  - Aged, 80 and over
KW  - Antineoplastic Combined Chemotherapy Protocols
KW  - administration & dosage
KW  - Benzamides
KW  - Disease-Free Survival
KW  - Female
KW  - Follow-Up Studies
KW  - Fusion Proteins, bcr-abl
KW  - genetics
KW  - Humans
KW  - Imatinib Mesylate
KW  - Male
KW  - Middle Aged
KW  - Piperazines
KW  - Precursor Cell Lymphoblastic Leukemia-Lymphoma
KW  - drug therapy
KW  - Pyrimidines
KW  - Remission Induction
KW  - Steroids
KW  - Survival Rate
N1  - Publication Type: Clinical Trial; Comparative Study; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1182/blood-2006-10-052746
ER  -